Search - tctmd.com

Displaying 161 - 180 of 392

Sort: Relevancy | Date

News Daily News

Italian Registry Cautions Against TAVR in Low-Risk Patients

L.A. McKeown

May 16, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Shelley Wood

March 28, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

Presentation TCT 2015

Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Jeffrey J. Popma

October 15, 2015

Presentation TCT 2015

Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Susheel Kodali

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem, Ronald M. Lazar

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

Assessing Postdevice Paravalvular Aortic Regurgitation

Presenter: Jeroen J. Bax, Paul A. Grayburn, Rebecca T. Hahn

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

Presentation TCT 2015

Mild-to-Moderate Paravalvular Aortic Regurgitation After TAVR: Thoughtful Commentary on the Case

Presenter: D. Craig Miller, Alec S. Vahanian, Samir R. Kapadia

October 12, 2015

Presentation TCT 2015

Mild-to-Moderate Paravalvular Aortic Regurgitation After TAVR: Case Presentation

Presenter: D. Craig Miller, Alec S. Vahanian, Anita Asgar

October 12, 2015

News Conference News TCT 2015

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

October 12, 2015

Advertisement

Italian Registry Cautions Against TAVR in Low-Risk Patients

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Paravalvular Regurgitation After TAVR 2: Importance of Valve Sizing and Calcium Patterns to Predict and Prevent Paravalvular Regurgitation After TAVR

Paravalvular Regurgitation After TAVR 1: KEYNOTE LECTURE Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Stroke After TAVR 3: Controversy 2 Importance and Methods of Neurocognitive Functional Assessments

Stroke After TAVR 2: Controversy 1 Need for Cerebral Protection (Universal vs Selective)

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Assessing Postdevice Paravalvular Aortic Regurgitation

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

Companies With Innovative Technologies Compete in TCT Shark Tank

Mild-to-Moderate Paravalvular Aortic Regurgitation After TAVR: Thoughtful Commentary on the Case

Mild-to-Moderate Paravalvular Aortic Regurgitation After TAVR: Case Presentation

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content